1. Home
  2. NVCR vs VIAV Comparison

NVCR vs VIAV Comparison

Compare NVCR & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VIAV
  • Stock Information
  • Founded
  • NVCR 2000
  • VIAV 1923
  • Country
  • NVCR Switzerland
  • VIAV United States
  • Employees
  • NVCR N/A
  • VIAV N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VIAV Semiconductors
  • Sector
  • NVCR Health Care
  • VIAV Technology
  • Exchange
  • NVCR Nasdaq
  • VIAV Nasdaq
  • Market Cap
  • NVCR 1.9B
  • VIAV 2.0B
  • IPO Year
  • NVCR 2015
  • VIAV 1993
  • Fundamental
  • Price
  • NVCR $19.11
  • VIAV $9.11
  • Analyst Decision
  • NVCR Buy
  • VIAV Buy
  • Analyst Count
  • NVCR 6
  • VIAV 8
  • Target Price
  • NVCR $32.83
  • VIAV $12.69
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • VIAV 2.9M
  • Earning Date
  • NVCR 07-24-2025
  • VIAV 05-01-2025
  • Dividend Yield
  • NVCR N/A
  • VIAV N/A
  • EPS Growth
  • NVCR N/A
  • VIAV N/A
  • EPS
  • NVCR N/A
  • VIAV 0.02
  • Revenue
  • NVCR $621,711,000.00
  • VIAV $1,045,800,000.00
  • Revenue This Year
  • NVCR $5.56
  • VIAV $10.06
  • Revenue Next Year
  • NVCR $9.15
  • VIAV $7.08
  • P/E Ratio
  • NVCR N/A
  • VIAV $398.76
  • Revenue Growth
  • NVCR 18.27
  • VIAV 3.34
  • 52 Week Low
  • NVCR $14.17
  • VIAV $6.60
  • 52 Week High
  • NVCR $34.13
  • VIAV $12.91
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • VIAV 36.85
  • Support Level
  • NVCR $18.66
  • VIAV $8.92
  • Resistance Level
  • NVCR $20.06
  • VIAV $9.36
  • Average True Range (ATR)
  • NVCR 0.86
  • VIAV 0.21
  • MACD
  • NVCR 0.19
  • VIAV 0.03
  • Stochastic Oscillator
  • NVCR 71.98
  • VIAV 26.97

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

Share on Social Networks: